Digital maturity of clinical operations at several big pharma firms varies significantly with the gap between best-in-class and the industry average narrowest for site selection tools, recruitment capabilities, and automation, a study has indicated. Digital patient experience tools figure among the least mature capabilities.

Executives from GlaxoSmithKline, Boehringer Ingelheim, Novo Nordisk, Eli Lilly and Ipsen outline at a recent summit pharma’s efforts to meet the growing demands on content for personalized marketing across markets. Delivering "glocal' content at scale, a master versus modular strategy, creative studios and the role of the digital production factory were some of the key talking points.

Boehringer Ingelheim’s corporate senior vice president, head of global regions, Timmo Rousku Andersen, outlines at a recent summit the company’s reshaped approach to digital innovation and the need to entrench an execution bias to scale transformation initiatives.